PET examination of three potent cocaine derivatives as specific radioligands for the serotonin transporter

Nuclear Medicine and Biology

Volumn 26, Issue 5, 1999, Pages 491-499

  Helfenbein, Julie ^a   Sandell, Johan ^b   Halldin, Christer ^b   Chalon, Sylvie ^a   Emond, Patrick ^a   Okubo, Yoshiro ^b   Chou, Yuan Hwa ^b   Frangin, Yves ^a   Douziech, Laurence ^a   Gareau, Lucette ^a   Swahn, Carl Gunnar ^b   Besnard, Jean Claude ^a   Farde, Lars ^b   Guilloteau, Denis ^a  

^a INSERM   (France)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

5 HTT; Brain; Cocaine derivative; Monkey; PET; Serotonin transporter

Indexed keywords

1,2,3,5,6,10B HEXAHYDRO 6 (4 METHYLTHIOPHENYL)PYRROLO[2,1 A]ISOQUINOLINE; AMMONIUM DERIVATIVE; CARBON 11; CARBOXYLIC ACID DERIVATIVE; CITALOPRAM; COCAINE DERIVATIVE; DOPAMINE TRANSPORTER; METHYL IODIDE; MONOAMINE; N,N DIMETHYLFORMAMIDE; RADIOLIGAND; SEROTONIN;

ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BRAIN STEM; CONTROLLED STUDY; DRUG POTENCY; DRUG STRUCTURE; DRUG SYNTHESIS; HYDROLYSIS; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; RADIOACTIVITY; THALAMUS;

EID: 0032773868     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-8051(99)00004-9     Document Type: Article

References (36)

1. Bergström K.A., Halldin C., Hall H., Lundkvist C., Ginovart N., Swahn C.G., Farde L. In vitro and in vivo characterisation of nor-β-CIT: A potential radioligand for visualisation of the serotonin transporter in the brain. Eur. J. Nucl. Med. 24:1997;596-601.
2. Blough B.E., Abraham P., Lewin A.H., Kuhar M.J., Boja J.W., Carroll F.I. Synthesis and transporter binding properties of 3β-(4′-alkyl-, 4′-alkenyl-, and 4′-alkynylphenyl)nortropane-2β-carboxylic acid methyl esters Serotonin transporter selective analogs . J. Med. Chem. 39:1996;4027-4035.
3. Boja J.W., Kuhar M.J., Kopajtic T., Yang E., Abraham P., Lewin A.H., Carroll F.I. Secondary amine analogues of 3β-(4′-substituted phenyl)tropane-2β-carboxylic acid esters and N-norcocaine exhibit enhanced affinity for serotonin and norepinephrine transporters. J. Med. Chem. 37:1994;1220-1223.
4. 125I]RTI-55 A potent ligand for dopamine transporters . Eur. J. Pharmacol. 194:1991;133-134.
5. 123I]β-CIT. J. Neural. Transm. 94:1993;137-146.
6. Carroll F.I., Kotian P., Dehghani A., Gray J.L., Kuzemko M.A., Parham K.A., Abraham P., Lewin A.H., Boja J.W., Kuhar M.J. Cocaine and 3β-(4′-substituted phenyl)tropane-2β-carboxylic acid ester and amide analogues. New high-affinity and selective compounds for the dopamine transporter. J. Med. Chem. 38:1995;379-388.
7. 3H]citalopram . Neuroscience. 54:1993;691-699.
8. Clarke R.L., Daum S.J., Gambino A.J., Aceto M.D., Pearl J., Levitt M., Cuminskey W.R., Bogado E.F. Compounds affecting the central nervous system. 4. 3β-phenyltropane-2-carboxylic esters and analogs. J. Med. Chem. 16:1973;1260-1267.
9. Dannals F.D., Scheffel U., Suehiro M., Ricaurte G. Radioligand development for studying serotonin uptake sites with positron emission tomography. Med. Chem. Res. 5:1994;228-244.
10. Davies H.M.L., Kuhn L.A., Thornley C., Matasi J.J., Sexton T., Childers S.R. Synthesis of 3 β-aryl-8-azabicyclo-[3.2.1]octanes with high binding affinities and selectivities for the serotonin transporter site. J. Med. Chem. 39:1996;2554-2558.
11. Davies H.M.L., Saikali E., Sexton T., Childers S.R. Novel 2-substituted cocaine analogs Binding properties at dopamine transport sites in rat striatum . Eur. J. Pharmacol. Mol. Pharmacol. Sec. 244:1993;93-97.
12. Emond P., Garreau L., Chalon S., Boazi M., Caillet M., Bricard J., Frangin Y., Mauclaire L., Besnard J.C., Guilloteau D. Synthesis and ligand binding of nortropane derivatives: N-substituted 2β-carbomethoxy-3β-(4′-iodophenyl)nortropane and N-(3-iodoprop-(2E)-enyl)-2β-carbomethoxy-3β-(3′,4′-disubstituted phenyl)nortropane. New high-affinity and selective compounds for the dopamine transporter. J. Med. Chem. 40:1997;1366-1372.
13. 11C]β-CIT binding to monoamine transporter in the monkey and human brain. Synapse. 16:1994;93-103.
14. 11C-Labelling of eticlopride in two different positions - A selective high-affinity ligand for the study of dopamine D-2 receptors using PET. Appl. Radiat. Isot. 41:1990;669-674.
15. Halldin C., Swahn C.-G., Farde L., Sedvall G. Radioligand disposition and metabolism. Comar D. Key information in early drug development. In PET for Drug Development and Evaluation . 1995;55-65 Kluwer Academic Publishers, Dordrecht, The Netherlands.
16. Helfenbein J., Emond P., Sandell J., Halldin C., Pereyre S., Frangin Y., Garreau L., Besnard J.-C., Guilloteau D. and Chalon S. (in press) Synthesis and radiolabelling of 2β-carbomethoxy-3β-(3′-iodo-4′-isopropylphenyl) nortropane. J. Labelled Compd. Radiopharm.
17. Hiltunen J., Åkerman K.K., Kuikka J.T., Bergström K.A., Halldin C., Nikula T., Räsänen P., Tiihonen J., Vauhkonen M., Karhu J., Kupila J., Länsimies E., Farde L. Iodine-123 labeled nor-β-CIT as a potential tracer for serotonin transporter imaging in the human brain with single-photon emission tomography. Eur. J. Nucl. Med. 25:1998;19-23.
18. Hume S.P., Pascali C., Pike V.W., Turton D.R., Ahier R.G., Myers R., Bateman D.M., Cremer J.E., Manjil L.G., Dolan R. Citalopram Labelling with carbon-11 and evaluation in rat as a potential radioligand for in vivo PET studies of 5-HT re-uptake sites . Nucl. Med. Biol. 18:1991;339-351.
19. Joyce J.N., Shane A., Lexow N., Winokur A., Casanova M.F., Kleinman J.E. Serotonin uptake sites and serotonin receptors are altered in the limbic system of schizophrenics. Neuropsychopharmacology. 8:1993;315-336.
20. 11C]NNC 756 as new radioligands for the D1-dopamine receptor. Psychopharmacology. 113:1993;149-156.
21. 11C]β-CIT labelled in two different positions. Nucl. Med. Biol. 26, 343-350.
22. 3H]cocaine binding sites in caudate-putamen. J. Pharmacol. Exp. Ther. 251:1989;131-141.
23. Milius R.A., Saha J.K., Madras B.K., Neumeyer J.L. Synthesis and receptor binding of N-substituted tropane derivatives. High-affinity ligands for the cocaine receptor. J. Med. Chem. 34:1991;1728-1731.
24. Mulholland G., Zheng Q.-H., Winkle W., Carlson K., Bledsoe S. and Zhou F. (1997) Brain serotonergic deficits measured in vivo in p-chloroamphetamine rats using novel carbon-11 labeled naphthyl- and isopropenylphenyl-tropane transporter ligands (Abstract 450.8). Society of Neuroscience 27th Annual Meeting Abstracts.
25. Owens M.J., Nemeroff C.B. Role of serotonin in the pathophysiology of depression Focus on the serotonin transporter . Clin. Chem. 40:1994;288-295.
26. Palmer A.M., Francis P.T., Benton J.S., Sims N.R., Mann D.M., Neary D., Snowden J.S., Bowen D.M. Presynaptic serotonergic dysfunction in patients with Alzheimer's disease. J. Neurochem. 48:1987;8-15.
27. Pike V.W. Radioligands for PET studies of central 5-HT receptors and re-uptake sites - current status. Nucl. Med. Biol. 22:1995;1011-1018.
28. Ritz M.C., Cone E.J., Kuhar M.J. Cocaine inhibition of ligand binding at dopamine, norepinephrine and serotonin transporters A structure-activity study . Life Sciences. 46:1990;635-645.
29. 11C]SCH 23390. Identification of two metabolites with HPLC. Human Psychopharmacol. 9:1994;25-31.
30. 125I-labelled β-CIT and its ω-fluoroalkylanalogues β-CIT-FE and β-CIT-FP, including synthesis of precursors. J. Labelled Compd. Radiopharm. 38:1996;675-685.
31. 11C](+)McN5652. Synapse. 20:1995;37-43.
32. 11C]McN5652. J. Cereb. Blood Flow Metab. 15:1995;798-805.
33. Tejani-Butt S.M., Yang J., Pawlyk A.C. Altered serotonin transporter sites in Alzheimer's disease raphe and hippocampus. NeuroReport. 6:1995;1207-1210.
34. Wienhard K., Dahlbom M., Eriksson L., Michel C., Bruckbauer T., Pietrzyk U., Heiss W.-D. The ECAT EXACT HR Performance of a new high resolution positron scanner . J. Comput. Assist. Tomogr. 18:1994;110-118.
35. 11C]β-CIT labeled at nitrogen and oxygen positions. Nucl. Med. Biol. 23:1996;981-986.
36. 11C]nor-β-CIPPT . J. Labelled Compd. Radiopharm. 39:1998;551-552.